Leukemia, Myeloid, Acute: all 3,035 studies

Page 31 of 31. Open to participants first (746), then studies with results posted, then the rest; newest registration first within each.

• Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00004896Phase 2
• Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00004871Phase 1
• Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00004862Phase 1
• Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00004263Phase 1
• Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic LeukemiaCompletedNCT00004245Phase 1
• S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00004217Phase 2
• Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00004215Phase 2
• Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00003991Phase 3
• Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaCompletedNCT00003934Phase 3
• Diagnostic Study of Gene Alterations in Patients With Acute Myeloid LeukemiaCompletedNCT00003931
• Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid LeukemiaCompletedNCT00003868Phase 2
• DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid LeukemiaCompletedNCT00003840Phase 1/2
• Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous LeukemiaStatus unknownNCT00003758Phase 2
• CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First RelapseCompletedNCT00003673Phase 2
• Combination Chemotherapy in Treating Older Patients With Acute Myeloid LeukemiaStatus unknownNCT00003602Phase 3
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid LeukemiaCompletedNCT00003436Phase 3
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous LeukemiaWithdrawnNCT00003405Phase 2
• Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNCT00003340Phase 2
• Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00003268Phase 1
• Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous LeukemiaCompletedNCT00003255Phase 2
• Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00003190Phase 3
• Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous LeukemiaCompletedNCT00003148Phase 2
• CMA-676 in Treating Patients With Acute Myeloid Leukemia in First RelapseCompletedNCT00003131Phase 2
• Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous LeukemiaCompletedNCT00003003Phase 1
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaStatus unknownNCT00002926Phase 3
• Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaCompletedNCT00002833Phase 2
• High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesCompletedNCT00002818Phase 1
• Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002805Phase 2
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second RemissionCompletedNCT00002768Phase 2
• Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid LeukemiaStatus unknownNCT00002658Phase 3
• Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First RelapseCompletedNCT00002554Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous LeukemiaStatus unknownNCT00002549Phase 3
• Trial to Reduce Alloimmunization to Platelets (TRAP)CompletedNCT00000589Phase 3

← Leukemia, Myeloid, Acute overview